CN1249233C - 肺炎衣原体表面蛋白 - Google Patents

肺炎衣原体表面蛋白 Download PDF

Info

Publication number
CN1249233C
CN1249233C CNB988064286A CN98806428A CN1249233C CN 1249233 C CN1249233 C CN 1249233C CN B988064286 A CNB988064286 A CN B988064286A CN 98806428 A CN98806428 A CN 98806428A CN 1249233 C CN1249233 C CN 1249233C
Authority
CN
China
Prior art keywords
seq
ser
gly
thr
leu
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB988064286A
Other languages
English (en)
Chinese (zh)
Other versions
CN1261403A (zh
Inventor
斯万德·伯克伦德
根纳·克里斯蒂安森
K·克努森
A-S·赫布斯加德·彼泽森
P·迈金迪
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Locke Diagnostic Aps
Original Assignee
Locke Diagnostic Aps
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Locke Diagnostic Aps filed Critical Locke Diagnostic Aps
Publication of CN1261403A publication Critical patent/CN1261403A/zh
Application granted granted Critical
Publication of CN1249233C publication Critical patent/CN1249233C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/295—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Chlamydiales (O)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Gram-negative bacteria
    • C07K16/125—Gram-negative bacteria from Chlamydiales (O)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
CNB988064286A 1997-06-23 1998-06-19 肺炎衣原体表面蛋白 Expired - Fee Related CN1249233C (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK74497 1997-06-23
DK0744/1997 1997-06-23
DK0744/97 1997-06-23

Publications (2)

Publication Number Publication Date
CN1261403A CN1261403A (zh) 2000-07-26
CN1249233C true CN1249233C (zh) 2006-04-05

Family

ID=8097044

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB988064286A Expired - Fee Related CN1249233C (zh) 1997-06-23 1998-06-19 肺炎衣原体表面蛋白

Country Status (13)

Country Link
US (2) US7264941B1 (cg-RX-API-DMAC10.html)
EP (1) EP1007685B1 (cg-RX-API-DMAC10.html)
JP (1) JP4160640B2 (cg-RX-API-DMAC10.html)
CN (1) CN1249233C (cg-RX-API-DMAC10.html)
AT (1) ATE323164T1 (cg-RX-API-DMAC10.html)
AU (1) AU749382B2 (cg-RX-API-DMAC10.html)
BR (1) BR9810288A (cg-RX-API-DMAC10.html)
CA (1) CA2294651A1 (cg-RX-API-DMAC10.html)
DE (1) DE69834194T2 (cg-RX-API-DMAC10.html)
DK (1) DK1007685T3 (cg-RX-API-DMAC10.html)
ES (1) ES2264810T3 (cg-RX-API-DMAC10.html)
PT (1) PT1007685E (cg-RX-API-DMAC10.html)
WO (1) WO1998058953A2 (cg-RX-API-DMAC10.html)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6710033B1 (en) 1996-08-14 2004-03-23 Vanderbilt University Methods and treatment of multiple sclerosis
US6890526B2 (en) 1997-05-06 2005-05-10 Vanderbilt University Methods and reagents for the treatment of multiple sclerosis
US6649370B1 (en) * 1998-10-28 2003-11-18 Aventis Pasteur Limited Chlamydia antigens and corresponding DNA fragments and uses thereof
EP1129202A2 (en) * 1998-10-28 2001-09-05 Aventis Pasteur Limited Chlamydia antigenes and corresponding dna fragments and uses thereof
US6872814B2 (en) * 1998-10-29 2005-03-29 Aventis Pasteur Limited Chlamydia antigens and corresponding DNA fragments and uses thereof
NZ512308A (en) * 1998-12-01 2004-01-30 Aventis Pasteur Chlamydia antigens and corresponding DNA fragments and uses thereof
AU3790900A (en) 1998-12-01 2000-06-19 Aventis Pasteur Limited Chlamydia antigens and corresponding DNA fragments and uses thereof
EP2172214A3 (en) 1999-03-12 2011-03-16 Aventis Pasteur Limited Chlamydia antigens and corresponding DNA fragments and uses thereof
WO2000066739A2 (en) * 1999-05-03 2000-11-09 Aventis Pasteur Limited Chlamydia antigens and corresponding dna fragments and uses thereof
CA2385325C (en) * 1999-09-20 2012-04-10 Aventis Pasteur Limited Chlamydia antigens and corresponding dna fragments and uses thereof
US20010048927A1 (en) 2000-02-01 2001-12-06 Richard Stephens Porin B (PorB) as a therapeutic target for prevention and treatment of infection by chlamydia
ATE440861T1 (de) * 2000-07-03 2009-09-15 Novartis Vaccines & Diagnostic Immunisierung gegen chlamydia pneumoniae
US7105171B2 (en) 2002-03-07 2006-09-12 The Regents Of The University Of California Porin B (PorB) as a therapeutic target for prevention and treatment of infection by Chlamydia
EP3452197A4 (en) 2016-05-04 2020-01-22 Children's Hospital & Research Center at Oakland FAST EXTRACTION OF NUCLEIC ACIDS FROM CLINICAL SAMPLES FOR DOWNSTREAM APPLICATIONS
US20220221456A1 (en) * 2019-05-06 2022-07-14 Arocell Ab Respiratory infection detection and classification

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU692889B2 (en) * 1994-08-03 1998-06-18 Hitachi Chemical Company, Ltd. Monoclonal antibodies having a reactivity specific to Chlamydia pneumoniae, method for production of the monoclonal antibodies, such antibody producing cells, method for production of the cells, method for detection and/or measurement of Chlamydia pneumoniae, reagents for the method, method and agents for diagnosis of chlamydia pneumoniae infection
CN100365017C (zh) 1994-09-20 2008-01-30 日立化成工业株式会社 肺炎衣原体抗原多肽
US6248329B1 (en) * 1998-06-01 2001-06-19 Ramaswamy Chandrashekar Parasitic helminth cuticlin nucleic acid molecules and uses thereof

Also Published As

Publication number Publication date
ATE323164T1 (de) 2006-04-15
US20080226679A1 (en) 2008-09-18
JP2002510970A (ja) 2002-04-09
EP1007685A2 (en) 2000-06-14
ES2264810T3 (es) 2007-01-16
WO1998058953A2 (en) 1998-12-30
AU749382B2 (en) 2002-06-27
PT1007685E (pt) 2006-08-31
AU8011998A (en) 1999-01-04
DK1007685T3 (da) 2006-08-14
WO1998058953A3 (en) 1999-03-18
US7264941B1 (en) 2007-09-04
DE69834194D1 (de) 2006-05-24
DE69834194T2 (de) 2007-03-29
BR9810288A (pt) 2000-09-19
CN1261403A (zh) 2000-07-26
EP1007685B1 (en) 2006-04-12
JP4160640B2 (ja) 2008-10-01
CA2294651A1 (en) 1998-12-30

Similar Documents

Publication Publication Date Title
CN1159441C (zh) 粘膜炎莫拉菌的uspa1和uspa2抗原
CN1145697C (zh) 治疗和诊断组合物
CN1222618C (zh) 卡他摩拉克菌外膜蛋白-106多肽及其基因序列和用途
CN1268745C (zh) B组链球菌抗原
CN1201818C (zh) 疫苗
CN1284965A (zh) 脑膜炎奈瑟氏球菌的新表面蛋白
CN1437653A (zh) 抗原多肽
CN1192241A (zh) Hsp70家族的链球菌热休克蛋白
CN1261896A (zh) 诊断和预防莱姆病用的组合物的表面抗原和蛋白质
CN1203180C (zh) 来自脑膜炎奈瑟氏球菌的basb006多核苷酸和多肽
CN1166858A (zh) tagA基因以及检测消化性溃疡和胃癌易感性的方法
CN1628249A (zh) 副结核分枝杆菌感染的诊断和疫苗
CN1261403A (zh) 新的肺炎衣原体表面蛋白
CN1198918C (zh) 减毒的活胸膜肺炎放线杆菌
CN1856505A (zh) 分泌型衣原体多肽、其编码多核苷酸及其治疗和诊断用途
CN1849334A (zh) 胞内劳森氏菌亚单位疫苗
CN1204253C (zh) 奈瑟氏球菌乳铁蛋白结合蛋白
CN1906210A (zh) 表面定位的空肠弯曲杆菌多肽
CN1322249A (zh) 脑膜炎奈瑟氏球菌抗原性多肽、相应多核苷酸和保护性抗体
CN1653084A (zh) 酶活性减少的非典型流感嗜血杆菌的p4蛋白突变体
CN1326508A (zh) 脑膜炎奈瑟氏球菌(Neisseria meningitidis)的多核苷酸和多肽BASB033及其用途
CN1198931C (zh) 粘膜炎莫拉氏菌basb034多肽及应用
CN1210401C (zh) 源自粘膜炎莫拉氏菌的化合物
CN1545552A (zh) 基因和蛋白质及它们的用途
CN1748791A (zh) 人和牲畜预防用出血性大肠杆菌o157:h7疫苗及制备方法

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee